We also showed that despite a potential interaction between ET-1 and SGLT-2 in the proximal renal tubule, the benefits of dapagliflozin were consistent across the range of serum ET-1 concentrations measured in DAPA-HF. This evidence concerns the gene SLC5A2 and hydrops fetalis.